+91 888 589 6523CONTACT US
0item(s)

You have no items in your shopping cart.

Product was successfully added to your shopping cart.

Computational Medicine and Drug Discovery Software Market

Details

Computational Medicine and Drug Discovery Software, as the name suggests: Computational medicine is an interdisciplinary subject that goes for creating innovative solutions for important clinical problems to improve human health. There are many clinical applications of computational medicine which help in the process of data collection and development of tools for clinical decision making. Computational Medicine finds its roots in chemistry and quantum mechanics. The foundation of computational medicine is based upon database and constraint-based models.  Database is basically repositories of information which is used in constraint-based models to understand protein-ligand interaction. 

This report gives an in-depth segmentation of the market by tools and by application. It’s also segmented by key geographic regions like Americas, Europe and Asia-pacific. Cost analysis, pricing analysis and the overall competitive landscape of key players are also analysed in great detail in the report.

computational medicine and drug discovery sofware market


Competitive landscape for each of the product types is highlighted and market players are profiled with attributes of company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of the key players for 2014 are provided. 

The prominent players profiled in this report are:

  • Schrodinger LLC,
  • Compugen Ltd.,
  • Chemical Computing Group Inc.,
  • Genedata AG
  • Nimbus Therapeutics Inc. along with several other companies.


The report contains the most detailed and in-depth segmentation of the global Computational Medicine and Drug Discovery Software market.

Details

1. Computational Medicine and Drug Discovery Software Market Overview
   1.1. Introduction
   1.2. Classification
      1.2.1. By Tools
            1.2.1.1. Databases
            1.2.1.2. Software
            1.2.1.3. Others
      1.2.2. By Application
            1.2.2.1. Computational Physiological Medicine
            1.2.2.2. Drug Discovery and Development
            1.2.2.3. Medical Imaging
            1.2.2.4. Disease Modelling
            1.2.2.5. Predictive Analysis of Drug Targets
            1.2.2.6. Cellular Simulation
            1.2.2.7. Simulation Software
      1.2.3. By Geography
            1.2.3.1. Americas
            1.2.3.2. Europe
            1.2.3.3. APAC
            1.2.3.4. ROW
2. Executive Summary
3. Computational Medicine and Drug Discovery Software Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
4. Computational Medicine and Drug Discovery Software - Market Forces
   4.1. Market Drivers
      4.1.1. The Rise of Bioinformatics in Drug Discovery
      4.1.2. Three Dimensional Drug Discovery Methodology
      4.1.3. Increase in Late Stage Drug Discovery Failure
   4.2. Market Challenges
      4.2.1. Lack of Skilled Professionals
      4.2.2. Complexity Associated With Analysis of Data
   4.3. Market Constraints
      4.3.1. Stringent Regulatory Approval for Novel Drugs
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New Entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Computational Medicine and Drug Discovery Software Market – Strategic Analysis
   5.1. Opportunity Analysis
      5.1.1. Cloud and Mobile Platforms Provides Investment Opportunities
      5.1.2. Enterprise Level Computational Softwares Holds Growth Prospects
   5.2. Value Chain Analysis
   5.3. Product/Industry Life Cycle Analysis
   5.4. Suppliers & Distributors
   5.5. Pricing Analysis
6. Computational Medicine and Drug Discovery Software Market – By Tools
   6.1. Introduction
   6.2. Database
   6.3. Software
   6.4. Others
7. Computational Medicine and Drug Discovery Software Market – By Application
   7.1. Introduction
   7.2. Computational Physiological Medicine
   7.3. Drug Discovery and Development
   7.4. Medical Imaging
   7.5. Disease Modeling
   7.6. Predictive Analysis of Drug Targets
   7.7. Cellular Simulation
   7.8. Simulation Software
8. Computational Medicine & Drug Discovery Software Market- By Geography
   8.1. Introduction
   8.2. Americas
      8.2.1. U.S.
      8.2.2. Canada
      8.2.3. Rest of Americas
   8.3. Europe
      8.3.1. U.K.
      8.3.2. Germany
      8.3.3. the Netherlands
      8.3.4. Norway
      8.3.5. Italy
      8.3.6. Rest of Europe
   8.4. APAC
      8.4.1. China
      8.4.2. Japan
      8.4.3. Korea
      8.4.4. Australia
      8.4.5. Rest of APAC
   8.5. Row
9. Market Entropy
   9.1. Most Preferred Strategy – Product Expansion
      9.1.1. Product Expansion
      9.1.2. Partnerships/Collaborations
      9.1.3. Other Developments (2011-2015)
10. Company Profiles
   10.1. Entelos, Inc.
      10.1.1. Business Overview
      10.1.2. Financials
      10.1.3. Products
      10.1.4. Developments
   10.2. Genedata Ag
      10.2.1. Business Overview
      10.2.2. Financials
      10.2.3. Products
      10.2.4. Developments
   10.3. Crown Bioscience Inc.
      10.3.1. Business Overview
      10.3.2. Financials
      10.3.3. Products
      10.3.4. Developments
   10.4. Biognos Ab
      10.4.1. Business Overview
      10.4.2. Financials
      10.4.3. Products
      10.4.4. Developments
   10.5. Chemical Computing Group Inc.
      10.5.1. Business Overview
      10.5.2. Financials
      10.5.3. Products
      10.5.4. Developments
   10.6. Leadscope, Inc.
      10.6.1. Business Overview
      10.6.2. Financials
      10.6.3. Products
      10.6.4. Developments
   10.7. Nimbus Therapeutics, Inc.
      10.7.1. Business Overview
      10.7.2. Financials
      10.7.3. Products
      10.7.4. Developments
   10.8. Rhenovia Pharma Limited
      10.8.1. Business Overview
      10.8.2. Financials
      10.8.3. Products
      10.8.4. Developments
   10.9. Schrödinger, Llc
      10.9.1. Business Overview
      10.9.2. Financials
      10.9.3. Products
      10.9.4. Developments
   10.10. Compugen Ltd.
      10.10.1. Business Overview
      10.10.2. Financials
      10.10.3. Products
      10.10.4. Developments
   10.11. Dassault Systemes
      10.11.1. Business Overview
      10.11.2. Financials
      10.11.3. Products
      10.11.4. Developments
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Acronyms
   11.2. Patents
   11.3. Research Methodology

Details

List of Tables :

Table 1. Computational Medicine and Drug Discovery Software Market: Top Companies With Rankings, 2015
Table 2. Regional Markets and Their Life Cycle Stages
Table 3. Databases for Genome and Proteome Annotation
Table 4. Softwares for Genome Annotation
Table 5. Drug Discovery & Development Process
Table 6. Global Computational Medicine and Drug Discovery Software Market, By Region, 2014-2020 ($Million)
Table 7. Americas: Computational Medicine and Drug Discovery Software Market, By Tools, 2014-2020 ($Million)
Table 8. Americas: Computational Medicine and Drug Discovery Software Market, By Application, 2014-2020 ($Million)
Table 9. Americas: Computational Medicine and Drug Discovery Software Market, By Country, 2014-2020 ($Million)
Table 10. Europe: Computational Medicine and Drug Discovery Software Market, By Tools, 2014-2020 ($Million)
Table 11. Europe: Computational Medicine and Drug Discovery Software Market, By Application, 2014-2020 ($Million)
Table 12. Europe: Computational Medicine and Drug Discovery Software Market, By Country, 2014-2020 ($Million)
Table 13. Apac: Computational Medicine and Drug Discovery Software Market, By Tools, 2014-2020 ($Million)
Table 14. Apac: Computational Medicine and Drug Discovery Software Market, By Application, 2014-2020 ($Million)
Table 15. Apac: Computational Medicine and Drug Discovery Software Market, By Country, 2014-2020 ($Million)
Table 16. Computational Medicine and Drug Discovery Software Market: Product Expansion
Table 17. Computational Medicine and Drug Discovery Software Market: Partnerships/Collaboration
Table 18. Biognos Ab: Products and Applications
Table 19. Chemical Computing Group Inc: Products and Applications
Table 20. Compugen Ltd. : Products and Applications
Table 21. Dassault Systèmes: Computational Medicine and Drug Discovery Software Products and Applications

 
List of Figures :

Figure 1. Computational Medicine and Drug Discovery Software, Classification
Figure 2. Computational Medicine and Drug Discovery Software, By Tools
Figure 3. Computational Medicine and Drug Discovery Software, By Application
Figure 4. Computational Medicine and Drug Discovery Software, By Geography
Figure 5. Global Computational Medicine and Drug Discovery Market, 2014-2020 ($Millionillion)
Figure 6. Computational Medicine and Drug Discovery Market Share, By Geography, 2014 (%)
Figure 7. Computational Medicine and Drug Discovery Software Market: Value Chain
Figure 8. Global Computational Medicine and Drug Discovery Market Revenue, By Region, 2014 & 2020 ($Million)
Figure 9. Current and Future Focus Parameters
Figure 10. Global Cmdd Database Market Revenue, 2014-2020 ($Million)
Figure 11. Global Cmdd Software Market Revenue, 2014-2020 ($Million)
Figure 12. Global Cmdd Others Market Revenue, 2014-2020 ($Million)
Figure 13. Global Computational Medicine and Drug Discovery Software Market, By Application, 2014-2020 ($Million)
Figure 14. Global Cmdds Computational Physiological Medicine Market, 2014-2020 ($Million)
Figure 15. Global Cmdds Drug Discovery and Development Market, 2014-2020 ($Million)
Figure 16. Nhs Imaging Activities in England, 2014 (Units)
Figure 17. Global Cmdds Medical Imaging Market, 2014-2020 ($Million)
Figure 18. Global Cmdds Disease Modeling Market, 2014-2020 ($Million)
Figure 19. Global Cmdds Predictive Analysis of Drug Target Market, 2014-2020 ($Million)
Figure 20. Global Cmdds Cellular Simulation Market, 2014-2020 ($Million)
Figure 21. Global Cmdds Simulation Software Market, 2014-2020 ($Million)
Figure 22. U.S.: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)
Figure 23. Canadian Pharmaceutical Industry: R&D Expenditure, 2007-2013 ($Billion)
Figure 24. Canada: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)
Figure 25. Rest of Americas: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)
Figure 26. U.K.: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)
Figure 27. Germany: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)
Figure 28. the Netherlands: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)
Figure 29. Norway: Total Spending On Healthcare As A Percentage of Gdp At Market Prices, 1970-2014 (%)
Figure 30. Norway: Computational Medicine and Drug Discovery Software Market, 2014-2020 ($Million)
Figure 31. Italy: Total Spending On Healthcare As A Percentage of Gdp At Market Prices, 1970-2014 (%)
Figure 32. Italy: Computational Medicine and Drug Discovery Software Market, 2014-2020 ($Million)
Figure 33. Rest of Europe Computational Medicine and Drug Discovery Software Market, 2014-2020 ($Million)
Figure 34. Total Health Expenditure in Apac Countries, 2014 (% of Gdp)
Figure 35. China: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)
Figure 36. Japan: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)
Figure 37. Korea: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)
Figure 38. Australia: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)
Figure 39. Rest of Apac: Computational Medicine and Drug Discovery Software Market Revenue, 2014-2020 ($Million)
Figure 40. Healthcare Spending in Middle East and Africa, 2008-2014 ($Billion)
Figure 41. Row: Computational Medicine and Drug Discovery Software Market, By Tools, 2014-2020 ($Million)
Figure 42. Row: Computational Medicine and Drug Discovery Software Market, By Application, 2014-2020 ($Million)
Figure 43. Total Developments, By Type of Development, 2011-2015
Figure 44. Financial Performance, 2010-2014, ($Million)
Figure 45. Compugen Ltd. Total Revenue From Sales to Customers, By Region, 2014 (%)
Figure 46. Dassault Systemes: Financial Performance, 2012-2014, ($Billion)
Figure 47. Dassault Systemes: Total Revenue, By Region, 2014, (%)

Additional Information

Report Code HCR0016
Published On May 3, 2016
No. of pages 6789
Countries Canada, India
Therapeutic Class Cardiovascular, Dermatology, Genitourinary Disorders, Oncology, Pain, Women's and Male Health

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.

  1. Be the first to review this product

Write Your Own Review

Only registered users can write reviews. Please, log in or register

Regular Price: $6,250.00

Special Price $6,200.00

Regular Price: $6,250.00

Special Price $6,200.00